Form 4: Mannatech General Counsel Granted 10,000 Stock Options with Performance Vesting

Mannatech Inc.'s General Counsel, Erin Kemmler Barta, was granted 10,000 stock options with a strike price of $10.60, vesting over two years and immediately upon a change in control.

Summary

• Erin Kemmler Barta, General Counsel of Mannatech Inc. (MTEX), was granted 10,000 stock options on June 3, 2025.
• The options have an exercise price of $10.60 per share and are set to expire on June 3, 2035.
• The vesting schedule for these options is staggered: one-third vests immediately on the grant date (June 3, 2025), another one-third vests on the first anniversary (June 3, 2026), and the final one-third vests on the second anniversary (June 3, 2027).
• A key provision states that all unvested options will vest immediately in the event of a change in control of Mannatech.
• Following this transaction, Ms. Barta directly beneficially owns 19,000 derivative securities (stock options) and 3,000 shares of common stock.

Sentiment

Score: 6

Explanation: The grant of stock options to a key executive like the General Counsel is a positive step for corporate governance, aligning her incentives with the company's long-term stock performance. However, it's a routine compensation event and not indicative of significant operational or financial news, hence a moderately positive score.

Positives

• The grant of stock options aligns management's interests with shareholder value creation, as the options gain value only if the stock price increases above the exercise price of $10.60.
• The immediate vesting of a portion of the options provides immediate incentive, while the staggered vesting encourages long-term retention and performance of the General Counsel.
• The change of control clause provides an additional incentive for management in potential acquisition scenarios, ensuring their interests are protected.

Negatives

• Potential for future dilution if the options are exercised, which is a standard aspect of equity compensation plans.

Risks

• Standard dilution risk associated with equity compensation plans if the granted options are exercised in the future.
• The value of the options is contingent on the company's stock performance, meaning they could become worthless if the stock price remains below the exercise price of $10.60.

Future Outlook

The vesting schedule for the stock options indicates a commitment to retaining the General Counsel for at least two more years, aligning her incentives with the company's long-term performance. The inclusion of a change of control clause is a standard provision designed to protect executive interests in potential merger and acquisition scenarios.

Management Comments

• "One-third of the stock options vest on the date of grant, another one-third of the stock options vest on the first anniversary of the date of grant, and the remaining one-third of the stock options vest on the second anniversary of the date of grant."
• "Options will vest immediately in the event of a change in control."

Industry Context

Form 4 filings are routine disclosures for publicly traded companies, reporting changes in beneficial ownership by company insiders, including officers, directors, and significant shareholders. The grant of stock options is a common and widely accepted form of executive compensation across industries, primarily used to align the interests of management with those of the company's shareholders by incentivizing long-term stock price appreciation.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for minor dilution if options are exercised, but also improved alignment of management interests with shareholder value creation.
• Management: Increased equity stake and long-term incentive, fostering commitment to company performance.

Next Steps

• Continued vesting of stock options for Erin Kemmler Barta on June 3, 2026, and June 3, 2027.
• Potential exercise of options by Erin Kemmler Barta if Mannatech's stock price exceeds the $10.60 exercise price.

Key Dates

Keywords

Mannatech, MTEX, stock options, equity compensation, insider transaction, Form 4, General Counsel, Erin Kemmler Barta, executive compensation, vesting schedule